Clinical Trial Update: A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effectiveness and safety of paliperidone extended-release (Invega ER) tablets to prevent recurrence in adults with schiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Invega ER (paliperidone extended-release)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED